Previous Page  8 / 24 Next Page
Information
Show Menu
Previous Page 8 / 24 Next Page
Page Background

American Association of

Clinical Endocrinologists

26th Annual Meeting & Clinical Congress

3–7 MAY 2017 • AUSTIN, TEXAS, USA

Postpartum diabetes risk,

prognosis for patients

with diabetic ketoacidosis,

more intense treatment

of dyslipidemia, and heart

failure complication of type 2

diabetes, were among the

many studies presented at this

year’s AACE annual meeting.

The PracticeUpdate Editorial

Team reports.

Womenwith

gestational diabetes

requiring insulin

at higher risk of

postpartumdiabetes

Women with gestational diabetes

who require insulin during pregnancy

are at higher risk of postpartum

diabetes than those who do not

require insulin during pregnancy,

finds a retrospective review.

O

kpara Ukandu Igwe, MBBS, of

Lagos University Teaching Hospital,

Nigeria, set out to assess factors

associated with postpartum glucose testing

among women with gestational diabetes

mellitus and patterns of the results.

Eighty-five women diagnosed with gesta-

tional diabetes using a 75-g oral glucose

tolerance test from 2006 to 2015 at a ter-

tiary healthcare facility were studied.

Information concerning screening and

sociodemographic features within 6 to

12 weeks of delivery were collected. Pat-

terns of test results were assessed and

analyzed. Linear and logistic regression

models were employed to evaluate the

correlation between maternal age, parity,

body mass index, mode of treatment, and

results of postpartum screening.

Of the 85 women with gestational diabetes,

34 (40%) were tested during the 6- to 12-

week postpartum period. Mean patient age

was 36 ± 2 years. The majority of mothers

(58.8%, n = 50) had delivered two to three

children. A total of 65.9% (n = 56) had body

mass index ≥25kg/m

2

.

The majority of women who did not present

for postpartum testing followed a controlled

diet. Use of insulin during pregnancy and

testing between 6 to 12 weeks postpartum

were significantly correlated.

Among the mothers with gestational diabe-

tes were tested, 15.3% (n = 13) suffered from

impaired glucose tolerance while 7.05% (n

= 6) of mothers with gestational diabetes

who were diagnosed with diabetes melli-

tus. Abnormal postpartum results and use

of insulin therapy during pregnancy were

significantly correlated.

Gestational diabetes mellitus is defined

as any degree of glucose intolerance with

onset or first recognition during pregnancy.

Women with gestational diabetes are at

increased risk of recurrence and future

development of type 2 diabetes mellitus,

and need to be screened and followed

postpartum.

CONFERENCE COVERAGE

8

PRACTICEUPDATE DIABETES